The Diagnosis and Prognosis theme links the basic science theme to clinical services. There is a strong history of cutting-edge neuropathology research in Southampton which has significantly advanced the field. There are established clinical services in place for evaluation of dementia diagnosis and provision of care. Existing strengths include dementia diagnostic imaging, with an imaging physics department that has expertise in structural and functional imaging, modelling and scientific computing. The neuropsychology team within this theme provide clinical diagnostic support to the region, and have interests in diagnostic test development within a clinical environment.
Themes
Dementia Care and Prevention
Ultimately, dementia basic science and diagnostic advances need to be focused on the individual, their relationships and the wider community. This theme benefits from a strong research base in user-centred and care-delivery design, with particular focus on the dementia workforce. There is established work focusing on quality of life in dementia subgroups, and on evaluating the nature of care provision in the community. New models of care have been pioneered including digital self-management provision (My Medical Record).
Clinical Trials and Therapeutics
There is a long history of dementia, brain ageing and neurodegenerative disease trials in Southampton. The Memory Assessment and Research Centre (Moorgreen Hospital, Southern Health FT) has a strong track record of delivery in dementia trials and participated in the earliest trials of cognitive enhancing medication for dementia. At Southampton, the Neurosciences Research Group conducts Phase 2 and Phase 3 trials through the University Hospital Southampton NIHR CRF facility for a range of dementias.
Basic and Translational Science
This theme benefits from existing expertise in basic science focusing on cell biology, vascular pathophysiology and neuroinflammation. Areas of interest include the maternal influence on fetal cerebrovascular development, the effects of diabetes and anti-diabetic drugs on models of tauopathy and the toxicity of different tau species to aid a molecular level understanding of dementia biology. The theme has expertise in neuronal and glial biology, cerebrovascular drainage pathways and the role of neuroinflammation in neurodegeneration, brain ageing and dementia.